Xoma's manufacturing agreement with US univ

USA-based University Texas A&M and antibody developer Xoma have reached an agreement to explore options for the development and manufacture of antibodies and protein-based therapeutics.

The partners will work together to develop next-generation systems and processes to improve and accelerate protein and antibody manufacturing. More specifically, the organizations plan to discuss the design and establishment of a state-of-the-art manufacturing facility in Texas to spur academic research in diverse biological and bioengineering disciplines, and create a world-class biological manufacturing capacity.

For Xoma, the program is intended to provide access to new processes and technologies, additional manufacturing capacity, process development facilities, and research personnel that could help accelerate the translation of the firm's innovative technologies into the practice of biological manufacturing.